Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease

Ferric citrate has been reported to have the potential to reduce phosphate and increase iron availability in patients with chronic kidney disease. In the present study, we evaluated its safety and efficacy in phosphate reduction and iron supplementation in chronic kidney disease stage 3-5 requiring...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Mei-Yi, Chen, Ying-Chun, Lin, Chun-Hung, Wu, Yun-Chun, Tu, Yu-Kang, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739813/
https://www.ncbi.nlm.nih.gov/pubmed/29291028
http://dx.doi.org/10.18632/oncotarget.21990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739813/
https://www.ncbi.nlm.nih.gov/pubmed/29291028
http://dx.doi.org/10.18632/oncotarget.21990

Ejemplares similares